Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

Innovation Action · Running

TEN4CARE Tendon Engineering for Comprehensive Advanced Rehabilitation and Enhancement

Coordinator
Universita Degli Studi Di Pavia, Italy
Runs
1 September 2025 to 31 August 2029
Status
Running
EU funding
€7.9m
Total cost
—
Partners
16 organisations in 7 countries
Type
Innovation Action
Grant agreement
101178590

What the project is doing

In the project's own words, from its summary on CORDIS.

Every year, around 33 million musculoskeletal injuries are reported, 50% involving tendon and ligament injuries. Due to their diverse aetiology, there is no “one-fits-all” solution. TEN4CARE means a crucial opportunity for the EU Material and MedTech Industries to solve this challenge, by providing a technologically advanced, biomaterial-based medical device that can be applicable in the worst prognostic scenarios, generating a wide impact on the citizens health and wellbeing but also on the sustainability, resilience and business opportunities for the whole industrial sector.

We aim to achieve tendon integrity by amplifying the recruitment of cells from surrounding tissues and refining their homing capabilities. This effort will drive the production of extracellular matrix, effectively replacing compromised or absent tissue. The objective is to tackle health complexities linked to tendon and ligament disorders, promoting rapid recovery for acute or chronic conditions. TEN4CARE will develop an innovative strategy for tendon tissue engineering through the design of a medical device based on electromagnetic-responsive shape memory 4D nanocomposite fibrous hydrogel and a minimally invasive surgery to inject and anchor it to bridge tendons/ligaments, able to be implanted using minimally invasive surgery that can be a game changer, as will combine enhanced structural properties, shape memory, antibacterial activity and regenerative capabilities, driven by external forces like magnetic and electric fields.

We will get a GMP validated production process, coupled with a scale up, industrially-driven strategy and an early regulatory planning, completed by a regulatory roadmap for the sector and the implied communities; a detailed evaluation of Safety and Sustainability based on SSbD concepts, guiding our developments but also generating general guidelines and discussion for the whole sector and business models and exploitation plans for the transfer of the TEN4CARE products.

Topics

Who is involved

OrganisationCityCountryRole
Universita Degli Studi Di PaviaPaviaItalyCoordinator
Obelis SABruxelles / BrusselBelgiumParticipant
Rehabilitation in Multiple Sclerosis, ivzwLeuvenBelgiumParticipant
Stryker Trauma GmbHSchonkirchenGermanyParticipant
Acondicionamiento Tarrasense AssociacionTerrassaSpainParticipant
Biokeralty Research Institute AieVitoria-GasteizSpainParticipant
Fundacion Centro De Cirugia De Minima Invasion Jesus UsonCaceresSpainParticipant
Universidad De GranadaGranadaSpainParticipant
Innovation Commercial Pathways Company Limited by GuaranteeKillarneyIrelandParticipant
The Provost, Fellows, Foundation Scholars & the Other Members of Board, of the College of the Holy & Undivided Trinity of Queen Elizabeth Near DublinDublinIrelandParticipant
Greendecision SRLVeneziaItalyParticipant
Todeschini Mario SRLLeccoItalyParticipant
Universita Degli Studi Di MilanoMilanoItalyParticipant
International Iberian Nanotechnology LaboratoryBragaPortugalParticipant
Resonant Circuits LimitedLondonUnited KingdomParticipant
The Office of Health EconomicsLondonUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI